Related Experiment Videos
[Studies on functions of neutrophils in MPO-ANCA related glomerulonephiritis and plasma effect on MPO release from
1First Department of Internal Medicine, Kyorin University, School of Medicine, Tokyo, Japan.
Abstract:
In order to examine the role of myeloperoxidase (MPO) and neutrophil activation in the pathogenesis of MPO-ANCA related necrotizing crescentic glomerulonephritis (GN), we investigated MPO release and superoxide anion (O-2) production from the neutrophils in MPO ANCA related GN. Plasma effect on MPO release from neutrophils was also studied in MPO-ANCA related GN. Neutrophils and plasma were obtained from 10 patients with MPO-ANCA-related GN (A), 10 patients with MPO-ANCA non related GN (B) and 10 healthy controls (C). MPO release and O-2 production were assayed by using chemotactic factor, N-formyl-methionyl-leucyl-phenyalanine (FMLP) and cytochalasin B (CB). In MPO-ANCA related GN, MPO release and O-2 production were significantly higher than in the other groups. [MPO release (%) A: 43.02 +/- 18.33, B: 33.26 +/- 11.58, C: 19.73 +/- 8.38, sensitivity to FMLP (%) A: 894.56 +/- 381.96, B: 512.86 +/- 314.91, C: 301.12 +/- 139.8, O-2 production (nmoles/min/10(6) cells) A: 13.06 +/- 5.28, B: 3.57 +/- 2.02, C: 2.83 +/- 1.16] Furthermore, MPO release, sensitivity to FMLP and O-2 production were shown to increase in parallel with clinical disease activity. Plasma from MPO-ANCA related GN increased sensitivity to FMLP in neutrophils obtained from healthy controls [plasma concentration 1%, A: 311.5 +/- 110.3, B: 227.2 +/- 101.4, C: 215.5 +/- 93.7], and plasma from MPO-ANCA related GN suppressed %MPO release from neutrophils with MPO-ANCA related GN [plasma concentration 0.1%, A: 11.56 +/- 6.17, C: 15.51 +/- 8.01]. It was concluded that in patients with MPO-ANCA related GN, large amounts of MPO can be easily released from activated neutrophils and this might be influenced by some stimulating and suppressing factors contained in the plasma.
Insights
Myeloperoxidase (MPO) and neutrophil activation are key in MPO-ANCA related glomerulonephritis. Studies show increased MPO release and superoxide production in patients, correlating with disease activity and influenced by plasma factors.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Myeloperoxidase (MPO)-antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (GN) is a severe kidney disease.
- Neutrophil activation and MPO release are implicated in its pathogenesis.
Purpose of the Study:
- To investigate MPO release and superoxide anion (O-2) production from neutrophils in MPO-ANCA related GN.
- To assess the effect of plasma from MPO-ANCA related GN patients on neutrophil activation.
Main Methods:
- Collected neutrophils and plasma from 10 MPO-ANCA GN patients, 10 MPO-ANCA non-GN patients, and 10 healthy controls.
- Assayed MPO release and O-2 production using chemotactic factor N-formyl-methionyl-leucyl-phenyalanine (FMLP) and cytochalasin B (CB).
- Evaluated plasma effects on neutrophil activation markers.
Main Results:
- MPO release and O-2 production were significantly higher in MPO-ANCA GN patients compared to other groups.
- Neutrophil MPO release, FMLP sensitivity, and O-2 production correlated with clinical disease activity.
- Plasma from MPO-ANCA GN patients enhanced FMLP sensitivity in healthy neutrophils but suppressed MPO release in GN neutrophils.
Conclusions:
- Activated neutrophils readily release large amounts of MPO in MPO-ANCA related GN.
- Plasma factors in MPO-ANCA GN patients can modulate neutrophil activation, potentially influencing disease progression.